AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Multimodal Ultrasound in DBD Kidneys for Predicting Early Postoperative Renal Insufficiency Risk

Recruitingn/aAges 18 Years - anyAllBei Wang
💬

In plain words

What the trial is, and whether it could suit you

The objective of this observational study is to investigate the multimodal ultrasound parameters of kidneys from brain-dead organ donors prior to donation, in order to construct a predictive model for assessing the risk of early transplant renal dysfunction after kidney transplantation in recipients. The primary question this study aims to address is: Can multimodal ultrasound data from brain-dead organ donor kidneys accurately predict early post-transplant renal dysfunction? Ultrasonography, as a routine examination before organ donation, will be utilized, and the study results will be concluded within one year after participation in this study.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Recipient Study Participants Age ≥18 years; Underwent allogeneic kidney transplantation at this hospital; Signed informed consent form. Donor Study Participants Brain-deceased organ donors; Completed organ donation at the First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital of Shandong Province); Brain death criteria: Deep coma (with clear etiology and exclusion of reversible causes); Absence of brainstem reflexes; No spontaneous respiration; Confirmed by at least two confirmatory tests (SLSEP, EEG, TCD), with re-evaluation 12 hours after the initial determination. Standard Criteria Donor (SCD): * Age 10-39 years; * Cause of death unrelated to cerebrovascular disease; * Serum creatinine \<133 μmol/L; * No history of hypertension. Expanded Criteria Donor (ECD): * Age \>60 years; OR ② Age 50-59 years with two of the following three criteria: * Cause of death related to cerebrovascular disease; * Serum creatinine \<133 μmol/L; * History of hypertension. Signed informed consent form. Exclusion Criteria: * Recipient Study Participants Patients with multiple kidney transplants; Patients with follow-up duration less than 1 year; Patients experiencing irreversible loss of graft function due to postoperative complications (e.g., rejection, thrombosis, anastomotic stenosis, infection). Donor Study Participants Severe primary renal diseases (e.g., hypertensive nephropathy, diabetic nephropathy, renal tumors); Cases with unavailable ultrasound imaging data: Excessive respiratory motion in donors; Obesity or other factors affecting imaging quality. Individuals with allergic predisposition.
💊

What it tests

  • Multimodal Ultrasound
📍

Where

1 site
The First Affiliated Hospital of Shandong First Medical University
Jinan, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy